Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF784 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | ZNF786 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
mRNA | ZNF850 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZNF852 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
mRNA | ZNF853 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZNF865 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |